[1]
N. H. Greig, R. E. Becker, Q. Yu, and H. W. Holloway et al., “From natural products to Alzheimer experimental therapeutics, eserine based drugs as symptomatic and disease altering agents”, Progr Nutr, vol. 12, no. 1, pp. 58–63, May 2010, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/progressinnutrition/article/view/1013